https://www.bccdc.ca/health-professionals/clinical-resources/communicable-disease-control-manual/immunization
### Contents & introduction  

- [Table of Contents](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/TOC_Chapter_2.pdf "link opens in a new window")  
- [Introduction](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Introduction.pdf "link opens in a new window") | Overview of provider responsibilities, immunization competencies & opportunities for immunization  
- [Essential Immunization Services During Times of Severe Disruption](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Essential-immunization-services-times-severe-disruption.pdf) | Guidance on the prioritization and continuity of immunization services during times of severe disruption to health service delivery

### Parts 1-5

- [Part 1: Immunization Schedules](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Part_1_Schedules.pdf "link opens in a new window") | Routine immunization schedules by age, use of minimum intervals between vaccine doses, management of vaccine administration errors
- [Part 2: Immunization of Special Populations](https://www.bccdc.ca/Communicable-Disease-Control-Manual/_layouts/15/FIXUPREDIRECT.ASPX?WebId=49f29a7b-29b1-40c8-bceb-f990c592fc52&TermSetId=60218028-5070-424f-910d-a80011e8cf79&TermId=d2e47961-aa32-40a1-8fbb-f6c7d9f07d44) | Immunization of individuals at high risk, immunocompromised individuals, chronic medical conditions, occupation, lifestyle & other high-risk conditions 
- [Part 3: Management of Anaphylaxis in a Non-Hospital Setting](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Part_3_Anaphylaxis.pdf) | Recognition, management & reporting of anaphylaxis 
- [Part 4: Biological Products (Vaccines & Immune Globulins)](https://www.bccdc.ca/Communicable-Disease-Control-Manual/_layouts/15/FIXUPREDIRECT.ASPX?WebId=49f29a7b-29b1-40c8-bceb-f990c592fc52&TermSetId=60218028-5070-424f-910d-a80011e8cf79&TermId=4dc8ecbe-77df-4645-b547-88027fc054da) | Product-specific information on vaccines & immune globulins including eligibility, dosing & scheduling 
- [Part 5: Adverse Events Following Immunization](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Part_5_AEFI.pdf) | Recognition & reporting of an adverse event following immunization & implications for future immunization

### Appendices  

- [Appendix A: Informed Consent](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Appendix_A_InformedConsent.pdf) | Overview of the informed consent process as it relates to immunization
- [Appendix B: Administration of Biological Products](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Appendix_B_Administration.pdf)​ | Preparation & administration of vaccines, including the appropriate route & site
- [Appendix C: Contraindications and Precautions for Immunization](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Appendix_C_ContraindicationsPrecautions.pdf) | Consideration & assessment for contraindications, precautions & severe allergies to vaccine components
- [Appendix D: Reducing Immunization Injection Pain](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Appendix_D_RIIP.pdf) | Strategies for the reduction of pain & anxiety associated with injections
- [Appendix E: Management of Biologicals](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Appendix_E_ManagementBiologicals.pdf "link opens a new window") | Storage & handling of vaccines & immune globulins, management & reporting of cold chain incidents
- [Guidance for Receiving and Handling the Pfizer-BioNTech COVID-19 mRNA Vaccine (including dry ice procedures)](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Guidance_Receiving_Handling_Pfizer-BioNTech_COVID-19_Vaccine.pdf)  
- [Guidance for Receiving and Handling the Moderna COVID-19 mRNA Vaccine](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Guidance_Receiving_Handling_Moderna_COVID-19_Vaccine.pdf)  
- [Appendix F: Principles of Immunology](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Appendix_F_PrinciplesImmunology.pdf) | Basic concepts related to the immune system and the vaccine immune response   
    
### Supporting documents  

- [History of Immunization in BC](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/HistoryImmunization.pdf)  
- [Latex Content in Vaccines](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/LatexContent.pdf)
- [Relative Risks of Diseases & Immunization](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/RelativeRisks.pdf)
- [Vaccine Immunogenicity, Efficacy & Effectiveness](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/VaccineImmunogenicity.pdf) 
- [Immunogenic Components of Selected Vaccines](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/ImmunogenicComponents.pdf)
- [Non-Immunogenic Components of Vaccines](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/NonImmunogenicComponents.pdf)
- [Vaccine Development & Licensing](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/VaccineDevelopment.pdf)
- [Definitions](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/Definitions.pdf)
- [References](https://www.bccdc.ca/resource-gallery/Documents/Guidelines%20and%20Forms/Guidelines%20and%20Manuals/Epid/CD%20Manual/Chapter%202%20-%20Imms/ReferencesSupportingDocs.pdf)